请问有做过CAR-T细胞免疫疗法的朋友么？请教

我爸上个月刚被诊断为肝癌，目前瘤体8×10cm，afp80左右，医生认为手术切除有风险，建议做介入治疗，我在坛子里看，有病友做了介入后情况反而恶化，加速转移了，因此很担心。通过前期了解，有一种CAR-T细胞免疫疗法目前在治疗白血病和黑色素瘤上很成功，而目前有一家叫CARSgen的公司正好在做针对肝癌的CAR-T的临床I期试验，因此想问问坛子里的朋友，有没有做过CAR-T疗法的，效果怎么样？特别是针对实体瘤的。或者有没有其他的治疗方案建议啊？（医生说要养肝，不适合用多吉美等靶向药）

CARSgen的临床试验信息如下，有需要的朋友也可以看看：
Anti-GPC3 CAR T for Treating Patients With Advanced HCC
This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by RenJi Hospital
Sponsor:
RenJi Hospital
Information provided by (Responsible Party):
RenJi Hospital
ClinicalTrials.gov Identifier:
NCT02395250
First received: March 17, 2015
Last updated: NA
Last verified: March 2015
History: No changes posted

    Full Text View
    Tabular View
    No Study Results Posted
    Disclaimer
    How to Read a Study Record

  Purpose

The purpose of this study is to determine whether autologous T cells bearing chimeric antigen receptor that can specifically recognize glypican-3 (GPC3) is safe and effective for patients with relapsed or refractory hepatocellular carcinoma (HCC).

Condition         Intervention         Phase
Hepatocellular Carcinoma
        Biological: anti-GPC3 CAR T
        Phase 1

Study Type:         Interventional
Study Design:         Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title:         Autologous T Cells Redirected to GPC3 for Treating Patients With Advanced HCC